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Leishmania are protozoan parasites of mammals that have two discrete life
stages. They exist as extracellular promastigotes within the gut of the sandfly
vector and are introduced into the mammalian host when an infected insect
takes a blood meal. Subsequently, promastigotes are ingested by mononuclear
phagocytic cells, such as macrophages, and then convert into their intracellular
amastigote form (1). Considerable attention has been focused on understanding
the molecular basis ofparasite-host cell interactions. Current evidence indicates
that the uptake of Leishmania by macrophages is mediated by specific ligand-
receptor interactions involving molecules on the surface ofboth the parasite and
the host macrophage. Cell surface glycoproteins and/or glycoconjugates of
promastigotes have been implicated in the binding to macrophage receptors.
These include the major surface glycoprotein ofapparent mol wt 63,000 (2-4)
anda lipid-containing surface glycoconjugate (5). Specific macrophage receptors
thathavebeen shown to interact with ligands on thepromastigote surfaceinclude
the receptor for the complement component C3bi (CR3) (6-8), the man-
nose/fucose receptor (6, 9), and the receptor for advanced glycoprotein end-
products (10).
Immunity to Leishmania in man or in experimental animals may be induced
during recovery from infection with virulent organisms or by immunization with
various attenuated parasite preparations (1, 11). This suggests that protective
immunization may be possible and, therefore, there is considerable interest in
determining the molecular basis of acquired resistance. To identify Leishmania
membrane proteins that may mediate interactions with host macrophages or may
induce specific immunity, a Leishmania major DNA expression library has been
screened with rabbit antibodies against Leishmania membranes. Several clones
were identified and the two described in this report are ofparticular interest as
they encode two Leishmania proteins containing different regions of tandemly
repetitive amino acid sequences of 14 and 10 residues, respectively. The repeti-
tive nature of these Leishmania proteins is strikingly similar to several malaria
(12, 13) and trypanosome molecules (14, 15), where in malaria the repetitive
sequences have been implicated in evasion of host immunity (12, 13).
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L. major promastigotes, NIH S strain (16), were provided by Dr. N. Reiner
(University of British Columbia, Vancouver) and were maintained in tissue culture
medium 199 (Gibco Laboratories, Grand Island NY) supplemented with 10% FCS
(HyClone Laboratories, Logan, UT). Promastigotes ofLeishmania donovani 1-S,C12_p (17)
were generously provided by Dr. D. Dwyer (National Institutesof Health, Bethesda, MD)
and were grown in chemically defined RE-IX medium (Gibco Laboratories). Genotypes
of both strains were confirmed by comparison of genomic DNA fragment hybridization
patterns with known standard Leishmania strains (kindly carried out by Dr. T . Spithill,
Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia).
Construction and Screening ofDNA Libraries.
￿
The protocols of Huynh et al. (18) and
Young et al. (19) with modifications as described (20) were used to construct and screen
a Agtl l genomic expression library. L. major promastigote genomic DNA was partially
digested with the restriction enzymes Alu I or Hae III. The digests were combined, size-
separated, and ligated to Xgtl l arms and packaged as described (Stratagene Cloning
Systems, San Diego, CA). This procedure resulted in 2 X 10' phage and the library was
not amplified.
For screening, phage were plated on an Escherichia coli Y1090(r) (Stratagene) and
screened as described previously (20) with a rabbit antiserum prepared by immunization
with a purified membrane fraction prepared from L. major promastigotes (generously
provided by Dr. T. W. Pearson, University of Victoria, British Columbia). Bound anti-
bodies were detected using biotin-labeled anti-rabbit antibodies and avidin-biotin-perox-
idase complexes (ABC Vectastain reagents; Vector Laboratories, Inc., Burlingame, CA).
Peroxidase complexes were developed using 4-chloro-l-naphthol.
A X EMBL3 library was constructed using L. major genomic DNA that had been
partially digested with Sau IIIA following the procedures of Frischauf et al. (21). This
library was screened as described (22) using DNA probes that had been nick-translated
(23) with [32P1dATP.
Characterization of DNA Clones.
￿
DNA clones were analyzed by restriction mapping
using a variety of restriction enzymes. DNA fragments were subcloned from the original
agtII clones into the plasmid, pUC19, or the phage, M13mp19 (24), using standard
procedures. DNA sequence analysis was carried out using the dideoxy chain termination
technique (25) as described previously (22). In addition, exonuclease III deletion clones
were prepared and sequenced as described (26).
Southern Blot Analysis.
￿
Genomic DNA isolated from Leishmania promastigotes was
digested with a variety of restriction enzymes and transferred to nylon membranes
(Hybond-N; Amersham Corp., Oakville, Ontario). Blots were prehybridized, hybridized,
and washed following the manufacturer's protocol. DNA probes were labeled with ["Pl-
dATP by nick translation.
Northern Blot Analysis. Total RNA was isolated from Leishmania promastigote as
described by Chirgwin et al. (27) using cesium chloride gradients. Total RNA was size-
separated on agarose formaldehyde gels as described (28). RNA was transferred to nylon
membranes and hybridized as described above for Southern blot analysis.
Preparation ofAntifusion Protein 20 Antibodies.
￿
Phage lysates were prepared from clone
20 as described by Young et al. (19), except that after lysis and centrifugation the pellet
contained the majority of fusion protein and was, therefore, solubilized by boiling in 5%
SDS. Phage extracts were reduced and alkylated by the addition of dithiothreitol to 50
mM and heating for 10 min at 90'C followed by the addition of iodoacetamide to 200
mM and incubation at room temperature for a further 40 min. Excess dithiothreitol and
iodoacetamide were removed by dialysis against 500 times volume of 0.1 % SDS .
Rabbits were immunized with 3 biweekly injections of ^-500 ug clone 20 extract in
CFA and bled 2 wk after the last immunization.
Affinity Purification ofAntifusion Protein 20 Antibodies.
￿
Antibodieswere affinity-purified
by binding and elution from strips of nitrocellulose onto which fusion protein 20 had
been blotted. Proteins from clone 20 phage lysates were separated by SDS-PAGE and
transferred to nitrocellulose membrane (Amersham Corp.) using a transblot apparatus1816
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(Hoeffer Scientific Instruments, San Francisco, CA). The regions of the membrane that
contained fusion protein 20 were then excised and these strips were used to affinity-purify
the antifusion protein antibody. Rabbit serum was diluted 1:100 in 170 mM NaCl, 10
mM Tris, pH 7.5 (TBS),' 1% BSA and bound to the membrane strips, which had been
blocked with 3% gelatin in TBS. After 60 min, unbound antibody was removed and the
membrane strips were sequentially washed with TBS, TBS + 0.05% Triton-X 100, 50
mM Tris (pH 7.5), andTBS. Antibody waseluted from themembrane strips by incubation
with 0.15 M NaCl, 50 mM diethylamine, 10 mM NaNs (pH 11 .2), 1% BSA for 10 min
with constant agitation. The eluted antibody was equilibrated to pH 7.0 with 1 M Tris-
HCI. Affinity-purified antibody was furtherdepleted of nonspecific phage lysate reactivity
by the addition of wild-type XgtI l bacterial lysate.
Western Blot Analysis of Leishmania Proteins and Phage Lysates.
￿
Total Leishmania pro-
teins, prepared by boiling 10' promastigotes per milliliter in 5% SDS, were reduced and
alkylated as described above. Samples were mixed with an equal volume of SDS-sample
buffer, boiled for 3 min, and separated by SDS-PAGE. Proteins were then transferred to
a synthetic membrane (Immobilon; Millipore, Bedford, MA) using a trans blot apparatus.
The membranes were handled according to the manufacturer's directions during the
blotting procedure and in the subsequent antibody-screening steps. Antibody staining was
carried out as describedabove.
Results
Identification ofLeishmania DNA Encoding Proteins Containing Tandemly Repeat-
ing Peptides. Rabbit antibodies against purified Leishmania membranes were
used to screen a L. major Xgt11 expression library. From a screen of 106 plaques,
40 positives were isolated and 2 strongly staining plaques were selected for
further study. These 2 clones, clones 20 and 39, contained Leishmania DNA
inserts of 3.6 kbp and 2.0 kbp, respectively. The orientation of the DNA inserts
in Xgt11 were determined and the insert fragments were subcloned into pUC19
and then into M13mp19 for DNA sequence determination. The DNA sequences
of a portion of the inserts of clones 20 and 39 were determined and are shown
in Fig. 1. The predictedamino acid sequences are striking, as each clone encodes
a different protein consisting of tandemly repeating peptides of a specific se-
quence and length. The two sequences are not related, clone 20 encodes a repeat
unit of 14 residues, while clone 39 encodes a repeat unit of 10 residues.
The restriction map of clone 20 is shown in Fig. 1 a. There were unique sites
within the clone for the restriction enzymes Xho I, Cla I, Bgl II, and Pvu II.
Each repeat unit has a unique site for the restriction enzyme Pst 1, which was
useful in determining the extent of the repeats within the clone. There are a
minimum of 20 repeat units in clone 20 DNA insert. DNA sequence analysis
and restriction mapping of clone 20 showed that the 5' end of clone 20 insert is
located within the repeats and that the repetitive sequence continues in the 3'
direction for 1.0 kbp. The sequence of the repeats is highly conserved at both
the nucleotide andthe amino acid level; changes that occur in the DNA sequence
do not result in amino acid substitutions. Following the repeat sequence were
177 by of coding sequence that terminated in a TAG stop codon. Clone 20,
therefore, contains 1.2 kbp of coding sequence, which corresponds to the 3' end
of the gene, and 1 .0 kbp of this sequence codes for a tandemly repeated peptide.
There is a potential glycosylation site, Asn-Val-Thr, 22 amino acids from the
COON-terminus and the penultimate amino acid is a cysteine residue. The
' Abbreviation used in this paper:
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Restriction map, DNAsequence analysis andpredicted protein sequence of agtI I
inserts . (a) Clone 20, (b) clone 39 . The shaded areas represent repetitive amino acid units .
The boxed regions represent DNA fragments that were used as probes in Southern and
Northern blots.
presence of a cysteine residue close to the COOH-terminus is of interest since
certain membrane proteins are anchored to the surface membrane by an unusual
lipid linkage possibly involving a COOH-terminus cysteine residue (29) .
The restriction map for clone 39 (Fig . 1 b) is different from that of clone 20 .1818
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FIGURE 2 .
￿
Analysis of L. major promastigote RNA using re-
petitive DNA probes labeled with [s2P]dATP . (a) Hybridized
with clone 20, probe A . (b) Hybridized with clone 39, probe C .
DNA fragments that were used as probes are shown in Fig. 1 .
The size markers used were an RNA ladder (Bethesda Research
Laboratories, Burlington, Ontario) and are indicated as kilo-
bases.
There are unique sitesfor the restriction enzymes Hind III and Bgl II . Sequence
analysis of the repeat units of clone 39 showed that they are unrelated to those
of clone 20 . There was a high degree of sequence conservation among clone 39
repeat units, although there was one amino acid substitution .
No crosshybridization was observed between the inserts of clone 20 and clone
39 ; however, it was possible that the two inserts corresponded to different
regions of the same gene . To determine whether clones 20 and 39 encode
different proteins, DNA fragments from each clone (probes A and C, see Fig . 1)
were used as hybridization probes in Northern blot analysis oftotal promastigote
RNA to determine the size of their correspondingRNA transcripts . The results
in Figure 2 show that clone 20 hybridized to two RNA species of 9.5 and 5 .2
kb, while clone 39 hybridized to a RNA of 7.5 kb . Thus, clones 20 and 39
appear to correspond to different Leishmania genes . To examine whether the
two clones corresponded to species-specific transcripts, RNA analysis was also
carried out using promastigote RNA of L . donovani, the causative agent of
visceral leishmaniasis . L . donovani expressed RNA transcripts that hybridized to
probes prepared from clones 20 and 39 and the transcripts were of the same size
as those expressed by L. major (data not shown) . Thus, Leishmania species that
cause different disease symptoms express both genes 20 and 39 .
GenomicDNAfromL . major was used in Southern blot analysisand hybridized
with a fragment of clone 20 (probe A in Fig . 1) that contained repeat units (Fig .
3a) . For most restriction enzyme digests, there were two genomic fragments that
hybridized to this probe, even though this probe did not contain sites for the
restriction enzymes used . Two possible explanations of this result are that either
there is another group of repeat units upstream in the clone 20 gene or that
there are two copies of clone 20 gene in theLeishmania genome . To differentiate
between these two possibilities, a second probe from clone 20 was used which
overlapped the 3' end of the original probe extending into the 3' untranslated
region and lacked the repeat region (Probe B) . In a Southern blot hybridization,
this 3' probe hybridized to genomic DNA fragments of the same size as those
that hybridized to probe A (Fig . 36) . Thus, the most likely explanation for the
presence of two fragments in the Southern blot is the presence of two genes in
the Leishmania genome . These data, together with the Northern blot results
(Fig . 2) where clone 20 probeA hybridized to twoRNA transcripts, support the
contention that there are two genes corresponding to clone 20 in the Leishmania





Genomic DNA analysis using both repetitive and nonrepetitive probes . Genomic
DNA from L . major promastigotes was digested with the indicated restriction enzymes . DNA
was transferred to a nylon membrane and hybridized with DNA probes labeled with [' 4P]-
dATP . (a) Hybridized with clone 20, probeA. (b) Hybridized with clone 20, probe B. DNA
fragments that were used as probes are shown in Fig. 1 . The size markers used were a Hind
III digest of phage X DNA and are indicated as kilobase pairs .
probe A, which contains repeat sequence, was used . One interpretation of this
finding is that the two clone 20 genes contain different numbers of repeat units.
On Northern analysis this difference in intensity was not as apparent, perhaps
due to differential levels ofRNA transcription. Further screening of the XgtI l
library and an EMBL3 genomic library with clone 20 probes resulted in the
identification of three clones related to clone 20 . Restriction mapping of these
clones indicated that they corresponded to the gene represented by the less
intense fragments, which hybridize to probe A on a genomic blot and contain a
fewer number of repeat units than the XgtI l clone 20 . Thus, clone 20 corre-
sponds to the gene that gives rise to the more intense hybridizing fragments on
Southern analysis.
Southern blots hybridized with the insert from clone 39 indicated that there
is a single copy of this gene, or possibly two identical copies, in the Leishmania
genome (Fig . 4) . Genomic blots carried out with DNA digested with the restric-
tion enzymes Pvu II, Pst I, Sal I, and Bam HI all resulted in high molecular
weight fragments (>9 kbp) when hybridized with the DNA insert from clone 39
(Fig . 4) .
Identification ofLeishmania Proteins Containing Repeat Peptides.
￿
The antibody
used to screen the library was a polyclonal serum directed against Leishmania
membranes and was not useful foridentification of the correspondingLeishmania
proteins. Rabbit antibodies, therefore, were prepared by immunizing with par-
tially purified (3-galactosidase fusion protein synthesized in E . coli lysogens . The
fusion protein encoded by clone 20 had an apparent mol wt of 210,000 and
required complete reduction, alkylation,andboiling in 5% SDS for solubilization .
Rabbit antibodies to fusion protein 20 were prepared by immunizing with the
insoluble fraction from clone 20 lysate, after reduction, alkylation and boiling in
5% SDS . No fusion protein could be detected in lysogenic cultures of clone 39,
probably due to the instability fusion protein 39 (30) .
Antibodies against clone 20 fusion protein were then used to identify the1820
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FIGURE 4 . Genomic DNA analysis using clone 39 repetitive DNA.
Genomic DNA from L. major promastigotes was digested with the
indicated restriction enzymes. DNA was transferred to a nylon mem-
brane and hybridized with [s2P]dATP-labeled DNA probe clone 39,
probe C. DNA fragments that were used as probes are shown in Fig.
1 . The size markers used were an Eco RI/Bam HI digest of phage a
DNAand are indicated as kilobase pairs .
FIGURE 5.
￿
Identification of repetitive proteins.
Recombinant bacterial lysates and total proteins
from L . major promastigotes were subjected to
SDS-PAGE analysis, transferred to syntheticmem-
branes, and developed with anti-clone 20 fusion
protein antibodies absorbed with wild type agtI 1
lysate as described in Materials and Methods . (1-
3) developed with anti-clone 20 fusion protein
antibody absorbed further with wild-type xgtII
lysate; (4-6) developed with anti-clone 20 fusion
protein antibody absorbed further with clone 20
recombinant lysate . (1 and 4) Recombinant clone
20 bacterial lysate ; (2 and 5) wild-type XgtI I bac-
terial lysate ; (3 and 6) total L . majorpromastigote
proteins .
corresponding Leishmania protein. The results of Western blot analysis of total
L . major proteins, which were reduced and alkylated, are shown in Fig. 5 . The
anti-20 fusion protein antibody recognized a series of protein bands of apparent
mol wt 250,000. The prior addition of clone 20 total lysate completely blocked
this reaction against Leishmania proteins and greatly reduced the reaction with
clone 20 lysate while the prior addition of wild-type Xgt11 lysate had no blocking
effect (Fig . 5) . The recognition of these proteins was greatly enhanced by the
reduction and alkylation of the proteins before electrophoresis and transfer .
This may be due to the fact that the antibodies were raised against reduced and
alkylated fusion protein and may only recognize epitopes on denatured Leish-
mania proteins . The large size of the proteins reacting with antibodies against
clone 20 fusion protein correlates with the high molecular weight of the RNA
transcripts that hybridize with clone 20 DNA. The multiple bands detected on
the Western blot may represent slight differences in glycosylation or some other
form of posttranslational modification .
The anti-20 fusion protein antibody was used to surface-label promastigotes ;
however, no significant binding could be detected, presumably because this
antibody reacts only with protein that is completely denatured . Although the
antibodies used to identify clone 20 were raised against Leishmania membranes,WALLIS AND McMASTER
￿
1821
this does not rule out the possibility that the proteins are located intracellularly
or even secreted. Antipeptide antibodies to repeat units ofboth clone 20 and 39
are currently being produced to investigate further the localization ofthese two
Leishmania proteins.
Discussion
The host immune response to Leishmania is complex; however, it has been
clearly shown (1) that resolution ofan established infection and acquired resis-
tanceis dependentoncell-mediatedrather than humoralimmunity. Susceptibility
and resistance to Leishmania has been extensively studied in inbred strains of
mice. These studies have demonstrated that discrete genetic loci control both
innate and acquired resistance to L. donovani (1, 31). Innate resistance to L.
donovaniappears to involve an inherent difference in the ability of macrophages
to support parasite growth (31-34). Susceptibility to L. major in the mouse has
also been shown to be genetically determined (35, 36).
Studies in both animals and man have revealed a variety of means by which
Leishmania may evade host resistancemechanisms. Forexample, both L. donovani
and L. major have been shown to infect macrophages without inducing the
production of IL-1 (37, 38). In addition, once infected with L. donovani, murine
macrophages do not express MHC class 11 molecules in response to IFN-'y (39).
Furthermore, mouse strains susceptible to either L. donovani or L. major have
been reported to develop Leishmania-specific T suppressor cells (1, 40).
An additional potential mechanism that may contribute to defective host
resistance to Leishmania is evasionofan effectivehumoral response. A commonly
reported feature ofchronic Leishmania infections is polyclonal B cell activation
resulting in high levels of serum Ig containing parasite-specific antibody. For
reasons that are not clear, this B cell response appears to play no role in host
protection (1). Recently, it has been proposed that regions ofrepetitivepeptides,
which have been found in many malarial antigens, may play a role in immune
evasion and may contribute to chronic infection (12, 13). Thus, tandemly
repeated sequences may provide a complex network of crossreacting epitopes
thatoverstimulate B cells andinterfere withthe normal maturationofaneffective
antibody response. This may result in the failure to select or stimulate B cell
clones synthesizing high-affinity antibody (12). The observation that Leishmania,
a distinct protozoan species that causes chronic infection, also express proteins
containing regions of tandemly repeating amino acid sequence suggests that
these molecules may function in a similar manner and thereby confer a selective
advantage to these parasites.
Summary
A genomic Leishmania major DNA expression library was screened using
antibodies raised against L. major membranes. Two different clones were iden-
tified that encoded proteins containing regions of tandemly repeated peptides.
Clone 20 encodes a repetitive peptide of 14 amino acids, while clone 39 encodes
a repetitive peptide of 10 amino acids. DNA from clone 20 hybridized with two
RNA species of 9,500 and 5,200 nucleotides in length, while DNA from clone1822
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39 hybridized to a single RNA species of 7,500 nucleotides. Antibodies against
clone 20 fusion protein recognized a series of L. major proteins ofapparent mol
wt 250,000.
Regions of repetitive peptides is a characteristic shared by many malarial
protein antigens and this feature has been implicated in immune evasion. Intra-
cellular parasites such as Leishmania and Plasmodia, therefore, may have evolved
similar mechanisms consisting ofthe expression ofproteins containing tandemly
repeating peptides that are involved in immune evasion.
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